Alzheimer’s Disease: Diagnosis and Access to Experimental Drugs

Lord Patel Excerpts

Wednesday 3rd June 2026 Lords Chamber

[Baroness Blake of Leeds (Lab)]

I was reading an article about this very subject just this morning, and it is fascinating. I do not think we really know the half of what the impact of these drugs is going to be on the wider health of people. So yes, we need to keep a very close eye on it for unexpected consequences and, hopefully, in this case, unexpected benefits.

[Lord Patel (CB)]

I suggest that the Minister looks again at the evidence produced recently by Novo Nordisk, the manufacturer of Wegovy drugs for obesity reduction, to see whether what was just said still applies in the new study.

[Baroness Blake of Leeds (Lab)]

I am very willing to take the noble Lord’s advice, and I will seek out a copy as soon as I can after this session.